CHATTEM BUYS PHISODERM TRADEMARK RIGHTS FROM STERLING
This article was originally published in The Tan Sheet
Executive Summary
CHATTEM BUYS PHISODERM TRADEMARK RIGHTS FROM STERLING that cover use of the brand name and certain assets of the skin-care line in the U.S., Puerto Rico and Canada, the two companies announced on June 20. The terms of the sale were not disclosed.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning